QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
State or Other Jurisdiction of Incorporation or Organization
|
I.R.S. Employer Identification No.
|
|
|
|
|
Address of Principal Executive Offices
|
Zip Code
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Smaller reporting company
|
Emerging growth company
|
Form 10-Q
Page No.
|
|
PART I. FINANCIAL INFORMATION
|
|
Item 1 – Interim Condensed Consolidated Financial Statements (Unaudited)
|
|
4
|
|
|
|
5
|
|
|
|
6
|
|
|
|
7
|
|
|
|
8
|
|
9 |
|
23
|
|
30 |
|
30 |
|
PART II. OTHER INFORMATION
|
|
31
|
|
32
|
|
32
|
|
32
|
|
32
|
|
32
|
|
32
|
|
33 |
October 30,
|
January 30,
|
October 31,
|
||||||||||
2021
|
2021
|
2020
|
||||||||||
ASSETS
|
Unaudited | Unaudited | ||||||||||
CURRENT ASSETS
|
||||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
||||||
Restricted cash
|
|
|
|
|||||||||
Accounts receivable
|
|
|
|
|||||||||
Merchandise inventory
|
|
|
|
|||||||||
Prepaid expenses and other current assets
|
|
|
|
|||||||||
Total current assets
|
|
|
|
|||||||||
Restricted cash
|
|
|
|
|||||||||
Fixed assets, net
|
|
|
|
|||||||||
Operating lease right-of-use assets
|
|
|
|
|||||||||
Intangible assets, net
|
|
|
|
|||||||||
Cash Surrender Value
|
|
|
|
|||||||||
Other assets
|
|
|
|
|||||||||
TOTAL ASSETS
|
$
|
|
$
|
|
$
|
|
||||||
LIABILITIES
|
||||||||||||
CURRENT LIABILITIES
|
||||||||||||
Accounts payable
|
$
|
|
$
|
|
$
|
|
||||||
Short-term borrowings
|
|
|
|
|||||||||
Accrued expenses and other current liabilities
|
|
|
|
|||||||||
Current portion of operating lease liabilites
|
|
|
|
|||||||||
Current portion of PPP Loan
|
|
|
|
|||||||||
Total current liabilities
|
|
|
|
|||||||||
Operating lease liabilities
|
|
|
|
|||||||||
PPP Loan
|
|
|
|
|||||||||
Long-term debt
|
|
|
|
|||||||||
Other long-term liabilities
|
|
|
|
|||||||||
TOTAL LIABILITIES
|
|
|
|
|||||||||
SHAREHOLDERS’ EQUITY
|
||||||||||||
Preferred stock ($
|
|
|
|
|||||||||
Common stock ($
|
|
|
|
|||||||||
Additional paid-in capital
|
|
|
|
|||||||||
Treasury stock at cost (
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Accumulated deficit
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
TOTAL SHAREHOLDERS’ EQUITY
|
|
|
|
|||||||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$
|
|
$
|
|
$
|
|
October 30,
2021
|
October 31,
2020
|
October 30,
2021
|
October 31,
2020
|
|||||||||||||
Net revenue
|
$
|
|
$
|
|
$ | $ | ||||||||||
Cost of sales
|
|
|
||||||||||||||
Gross profit
|
|
|
||||||||||||||
Selling, general and administrative expenses
|
|
|
||||||||||||||
Loss from operations
|
(
|
)
|
(
|
)
|
( |
) | ( |
) | ||||||||
Interest expense
|
|
|
||||||||||||||
Other income |
( |
) | ( |
) | ||||||||||||
Income (loss) before income tax expense
|
(
|
)
|
(
|
)
|
( |
) | ( |
) | ||||||||
Income tax expense (benefit)
|
|
(
|
)
|
( |
) | |||||||||||
Net income (loss)
|
$
|
(
|
)
|
$
|
|
$ |
( |
) | $ |
( |
) | |||||
BASIC AND DILUTED INCOME PER SHARE:
|
||||||||||||||||
Basic income (loss) per common share
|
$
|
(
|
)
|
$
|
|
$ | ( |
) | $ | ( |
) | |||||
Weighted average number of common shares outstanding – basic
|
|
|
||||||||||||||
Diluted income (loss) per common share | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | ||||||
Weighted average number of common shares outstanding – diluted |
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended |
|||||||||||||||
October 30,
2021
|
October 31,
2020
|
October 30,
2021
|
October 31,
2020
|
|||||||||||||
Net income (loss)
|
$
|
(
|
)
|
$
|
|
$ | ( |
) | $ | ( |
) | |||||
Amortization of pension gain
|
|
|
||||||||||||||
Comprehensive income (loss)
|
$
|
(
|
)
|
$
|
|
$ | ( |
) | $ | ( |
) |
Thirteen Weeks Ended October 30, 2021
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Accumulated
Other
Comprehensive
Loss
|
Retained
Earnings
(Accumulated
Deficit)
|
Shareholders’
Equity
|
|||||||||||||||||||||||||||||
Common
Shares
|
Treasury
Shares
|
Common
Stock
|
Additional
Paid-in
Capital
|
Treasury
Stock
At Cost
|
||||||||||||||||||||||||||||
Balance as of July 31, 2021
|
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||||
Net income
|
-
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||
Issuance of warrants
|
|
-
|
|
|
|
|
|
|
||||||||||||||||||||||||
Exercise of stock options
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Common stock issued- Director grants
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
|
|
|
|
|
|
||||||||||||||||||||||||
Balance as of October 30, 2021
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
Thirty-nine Weeks Ended October 30, 2021
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Accumulated
Other
Comprehensive
Loss
|
Retained
Earnings
(Accumulated
Deficit)
|
Shareholders’
Equity
|
|||||||||||||||||||||||||||||
Common
Shares
|
Treasury
Shares
|
Common
Stock
|
Additional
Paid-in
Capital
|
Treasury
Stock
At Cost
|
||||||||||||||||||||||||||||
Balance as of January 30, 2021
|
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||||
Net Loss
|
-
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||
Issuance of warrants | - | ( |
) | |||||||||||||||||||||||||||||
Sales of shares, net of expense
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Exercise of stock options
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Common stock issued- Director grants
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
|
|
|
|
|
|
||||||||||||||||||||||||
Balance as of October 30, 2021
|
|
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
Thirteen Weeks Ended October 31, 2020
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Accumulated
Other
Comprehensive
Loss
|
Retained
Earnings
(Accumulated
Deficit)
|
Shareholders’
Equity
|
|||||||||||||||||||||||||||||
Common
Shares
|
Treasury
Shares
|
Common
Stock
|
Additional
Paid-in
Capital
|
Treasury
Stock
At Cost
|
||||||||||||||||||||||||||||
Balance as of August 1, 2020
|
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||||||||||
Net Loss
|
-
|
-
|
|
|
|
|
|
|
||||||||||||||||||||||||
Other comprehensive income
|
-
|
-
|
|
|
|
|
|
|
||||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
|
|
|
|
|
|
||||||||||||||||||||||||
Balance as of October 31, 2020
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
Thirty-nine Weeks Ended October 31, 2020
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Accumulated
Other
Comprehensive
Loss
|
Retained
Earnings
(Accumulated
Deficit)
|
Shareholders’
Equity
|
|||||||||||||||||||||||||||||
Common
Shares
|
Treasury
Shares
|
Common
Stock
|
Additional
Paid-in
Capital
|
Treasury
Stock
At Cost
|
||||||||||||||||||||||||||||
Balance as of February 1, 2020
|
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||||
Net Loss
|
-
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||
Other comprehensive income
|
-
|
-
|
|
|
|
|
|
|
||||||||||||||||||||||||
Vested restricted shares
|
|
(
|
)
|
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||||||||
Common stock issued- Director grants
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
|
|
|
|
|
|
||||||||||||||||||||||||
Balance as of October 31, 2020
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
Thirty-nine Weeks Ended
|
||||||||
October 30,
2021
|
October 31,
2020
|
|||||||
OPERATING ACTIVITIES:
|
||||||||
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
Depreciation of fixed assets
|
|
|
||||||
Amortization of intangible assets
|
|
|
||||||
Stock-based compensation
|
|
|
||||||
Amortization of ROU asset
|
|
|
||||||
Amortization of warrant interest
|
||||||||
Interest on long term debt
|
||||||||
Change in cash surrender value
|
(
|
)
|
(
|
)
|
||||
Reversal of ASC 740 liability
|
( |
) | ||||||
Forgiveness of PPP Loan
|
( |
) | ||||||
Changes in operating assets and liabilities that provide (use) cash:
|
||||||||
Accounts receivable
|
|
|
||||||
Merchandise inventory
|
(
|
)
|
(
|
)
|
||||
Prepaid expenses and other current assets
|
(
|
)
|
|
|||||
Other long-term assets
|
|
|
||||||
Accounts payable
|
(
|
)
|
|
|||||
Accrued expenses and other current liabilities
|
|
(
|
)
|
|||||
Other long-term liabilities
|
(
|
)
|
(
|
)
|
||||
Net cash used in operating activities
|
(
|
)
|
(
|
)
|
||||
INVESTING ACTIVITIES:
|
||||||||
Purchases of fixed assets
|
(
|
)
|
(
|
)
|
||||
Proceeds from sale of fye business
|
|
|
||||||
Net cash provided by (used in) investing activities
|
(
|
)
|
|
|||||
FINANCING ACTIVITIES:
|
||||||||
Proceeds from short term borrowings
|
|
|
||||||
Proceeds from long term borrowings
|
|
|
||||||
Proceeds from issuance of warrants
|
|
|
||||||
Proceeds from PPP loan
|
|
|
||||||
Proceeds from stock offering
|
||||||||
Proceeds from exercise of stock options
|
|
|||||||
Payments of PPP loan
|
( |
) | ||||||
Issuance of director deferred shares and RSUs
|
|
|
||||||
Payment of long term borrowings
|
( |
) | ||||||
Payment of short term borrowings
|
(
|
)
|
(
|
)
|
||||
Net cash provided by financing activities
|
|
|
||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash
|
(
|
)
|
(
|
)
|
||||
Cash, cash equivalents, and restricted cash, beginning of period
|
|
|
||||||
Cash, cash equivalents, and restricted cash, end of period
|
$
|
|
$
|
|
Partner Obsession
|
Insights Driven
|
Simplicity
|
Innovation
|
Results
|
Ownership
|
Diversity and Teamwork
|
October 30, 2021
|
||||||||||||||||||||
Weighted
Average
Amortization
Period
(in months)
|
Original
Gross
Carrying
Amount
|
Accumulated
Impairment
|
Accumulated
Amortization
|
Net
Carrying
Amount
|
||||||||||||||||
Technology
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||
Trade names and trademarks
|
|
|
|
|
|
|||||||||||||||
$
|
|
$
|
|
$
|
|
$
|
|
(amounts in thousands)
|
January 30,
2021
|
Impairment
Expense
|
Amortization
Expense
|
October 30,
2021
|
||||||||||||
Amortized intangible assets:
|
||||||||||||||||
Technology
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Trade names and trademarks
|
|
|
|
|
||||||||||||
Net amortized intangible assets
|
$
|
|
$
|
|
$
|
|
$
|
|
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
(amounts in thousands)
|
October 30,
2021
|
October 31,
2020
|
October 30,
2021
|
October 31,
2020
|
||||||||||||
Amortized intangible assets:
|
||||||||||||||||
Technology
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Trade names and trademarks
|
|
|
|
|
||||||||||||
Total amortization expense
|
$
|
|
$
|
|
$
|
|
$
|
|
October 30,
2021
|
January 30,
2021
|
October 31,
2020
|
||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
||||||
Restricted cash
|
|
|
|
|||||||||
Total cash, cash equivalents and restricted cash
|
$
|
|
$
|
|
$
|
|
Number of
Shares
Subject To
Option
|
Weighted Average Exercise
Price
|
Weighted Average Remaining Contractual Term
|
Other
Share
Awards
|
Weighted
Average
Grant Fair
Value
|
||||||||||||||||
Balance January 30, 2021
|
|
$
|
|
|
$ | |||||||||||||||
Granted
|
|
|
|
|||||||||||||||||
Forfeited
|
(
|
)
|
|
|
||||||||||||||||
Canceled
|
(
|
)
|
|
-
|
||||||||||||||||
Exercised
|
(
|
)
|
|
|
( |
) | ||||||||||||||
Balance October 30, 2021
|
|
$
|
|
|
$ | |||||||||||||||
Exercisable October 30, 2021
|
|
$
|
|
|
$ |
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
(amounts in thousands)
|
October 30,
2021
|
October 31,
2020
|
October 30,
2021
|
October 31,
2020
|
||||||||||||
Interest cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Amortization of net gain(1)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
Net periodic pension cost
|
$
|
|
$
|
|
$
|
|
$
|
|
• Partner Obsession
• Insights Driven
• Simplicity
• Innovation
|
• Results
• Ownership
• Diversity and Teamwork
|
Thirteen Weeks Ended
|
Change
|
Thirty-nine Weeks Ended
|
Change
|
|||||||||||||||||||||||||||
(amounts in thousands)
|
October 30,
2021
|
October 31,
2020
|
$ |
|
%
|
October 30,
2021
|
October 31,
2020
|
$ |
|
%
|
||||||||||||||||||||
Net Revenue
|
$
|
32,172
|
$
|
38,913
|
$
|
(6,741
|
)
|
-17.3
|
%
|
$
|
107,680
|
$
|
112,799
|
$
|
(5,119
|
)
|
-4.5
|
%
|
||||||||||||
Gross profit
|
8,004
|
9,601
|
(1,597
|
)
|
-16.6
|
%
|
26,636
|
28,204
|
(1,568
|
)
|
-5.6
|
%
|
||||||||||||||||||
% to sales
|
24.9
|
%
|
24.7
|
%
|
24.7
|
%
|
25.0
|
%
|
Thirteen weeks ended
|
Thirty-nine weeks ended
|
|||||||||||||||||||||||||||||||||||
October 30, 2021
|
October 31, 2020
|
Change
|
October 30,2021
|
October 31, 2020
|
Change
|
|||||||||||||||||||||||||||||||
Amazon US
|
$
|
30,423
|
94.6
|
%
|
$
|
36,221
|
93.1
|
%
|
-16.0
|
%
|
$
|
100,581
|
93.4
|
%
|
$
|
106,369
|
94.3
|
%
|
-5.4
|
%
|
||||||||||||||||
Amazon International
|
738
|
2.3
|
%
|
2,078
|
5.3
|
%
|
-65.5
|
%
|
4,295
|
4.0
|
%
|
5,076
|
4.5
|
%
|
-15.4
|
%
|
||||||||||||||||||||
Other Marketplaces
|
543
|
1.7
|
%
|
240
|
0.6
|
%
|
126.5
|
%
|
1,428
|
1.3
|
%
|
564
|
0.5
|
%
|
153.2
|
%
|
||||||||||||||||||||
Subtotal Retail as a Service
|
31,704
|
98.5
|
%
|
38,524
|
99.0
|
%
|
-17.7
|
%
|
106,304
|
98.7
|
%
|
112,009
|
99.3
|
%
|
-5.1
|
%
|
||||||||||||||||||||
Subscriptions
|
468
|
1.5
|
%
|
389
|
1.0
|
%
|
20.4
|
%
|
1,375
|
1.3
|
%
|
790
|
0.7
|
%
|
74.1
|
%
|
||||||||||||||||||||
Net revenue
|
$
|
32,172
|
100.0
|
%
|
$
|
38,913
|
100.0
|
%
|
-17.3
|
%
|
$
|
107,679
|
100.0
|
%
|
$
|
112,799
|
100.0
|
%
|
-4.5
|
%
|
Thirteen Weeks Ended
|
Change
|
Thirty-nine Weeks Ended
|
Change
|
|||||||||||||||||||||||||||
(amounts in thousands)
|
October 30,
2021
|
October 30,
2020
|
$ |
%
|
October 30,
2021
|
October 30,
2020
|
$ |
%
|
||||||||||||||||||||||
Merchandise margin
|
$
|
14,653
|
$
|
17,978
|
$
|
(3,325
|
)
|
-18.5
|
%
|
$
|
49,309
|
$
|
51,879
|
$
|
(2,570
|
)
|
-5.0
|
%
|
||||||||||||
% of net revenue
|
45.5
|
%
|
46.2
|
%
|
-0.7
|
%
|
45.8
|
%
|
46.0
|
%
|
-0.2
|
%
|
||||||||||||||||||
Fulfillment fees
|
(4,375
|
)
|
(6,479
|
)
|
2,104
|
-32.5
|
%
|
(16,218
|
)
|
(18,343
|
)
|
2,125
|
-11.6
|
%
|
||||||||||||||||
Warehousing and freight
|
(2,274
|
)
|
(1,898
|
)
|
(376
|
)
|
19.8
|
%
|
(6,455
|
)
|
(5,332
|
)
|
(1,123
|
)
|
21.1
|
%
|
||||||||||||||
Gross profit
|
$
|
8,004
|
$
|
9,601
|
$
|
(1,597
|
)
|
-16.6
|
%
|
$
|
26,636
|
$
|
28,204
|
$
|
(1,568
|
)
|
-5.6
|
%
|
||||||||||||
% of net revenue
|
24.9
|
%
|
24.7
|
%
|
24.7
|
%
|
25.0
|
%
|
Thirteen Weeks Ended
|
Change
|
Thirty-Nine Weeks Ended
|
Change
|
|||||||||||||||||||||||||||
(amounts in thousands)
|
October 30,
2021
|
October 31,
2020
|
$ |
|
%
|
October 30,
2021 |
October 31,
2020
|
$ |
|
%
|
||||||||||||||||||||
Selling expenses
|
$
|
4,580
|
$
|
5,710
|
$
|
(1,130
|
)
|
-19.8
|
%
|
$
|
15,571
|
$
|
16,578
|
$
|
(1,007
|
)
|
-6.1
|
%
|
||||||||||||
General and administrative expenses
|
5,438
|
4,503
|
935
|
20.8
|
%
|
15,315
|
17,909
|
(2,594
|
)
|
-14.5
|
%
|
|||||||||||||||||||
Total SG&A expenses
|
$
|
10,018
|
$
|
10,213
|
$
|
(195
|
)
|
-1.9
|
%
|
$
|
30,886
|
$
|
34,487
|
$
|
(3,601
|
)
|
-10.4
|
%
|
||||||||||||
As a % of total revenue
|
31.1
|
%
|
26.2
|
%
|
28.7
|
%
|
30.6
|
%
|
As of or for the
Thirty-Nine Weeks Ended |
Change | ||||||||||||
(amounts in thousands)
|
October 30,
2021 |
October 31,
2020 |
$
|
||||||||||
Operating Cash Flows
|
$
|
(9,990
|
)
|
$
|
(15,272
|
)
|
$
|
5,282
|
|||||
Investing Cash Flows
|
(1,047
|
)
|
10,884
|
(11,931
|
)
|
||||||||
Financing Cash Flows
|
10,125
|
3,004
|
7,121
|
||||||||||
Capital Expenditures(1)
|
(1,047
|
)
|
(935
|
)
|
(112
|
)
|
|||||||
Cash, Cash Equivalents, and Restricted Cash
|
(2)
|
5,644
|
7,428
|
(1,784
|
)
|
||||||||
Merchandise Inventory (2)
|
30,248
|
27,204
|
3,044
|
||||||||||
(1)
|
Included in Investing Cash Flows
|
||||||||||||
(2)
|
Cash and cash equivalents per condensed consolidated balance sheets
|
$
|
1,754
|
$
|
2,396
|
||||||||
Add: restricted cash
|
3,890
|
5,032
|
|||||||||||
Cash, cash equivalents, and restricted cash
|
$
|
5,644
|
$
|
7,428
|
(A) Exhibits -
Exhibit No.
|
Description
|
||
10.1 |
Amendment No. 3 to Loan and Security Agreement dated September 17, 2021 - incorporated by reference to Exhibit 10.1 to the Company's Form 8-K. Filed on September 20, 2021. Commission File No. 0-14818. | ||
10.2 |
Amendment No. 1 to Subordinated Loan and Security Agreement dated September 17, 2021 - incorporated by reference to Exhibit 10.2 to the Company's Form 8-K Filed on September 20, 2021. Commission File No. 0-14818. | ||
|
31.1 |
Chief Executive Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2 |
Chief Financial Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certification pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
|
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
|
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
|
104
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).
|
December 14, 2021
|
By: /s/ Kunal Chopra
|
|
Kunal Chopra
|
||
Chief Executive Officer
|
||
(Principal Executive Officer)
|
December 14, 2021
|
By: /s/ Edwin Sapienza
|
|
Edwin Sapienza
|
||
Chief Financial Officer
|
||
(Principal and Chief Accounting Officer)
|